TD Asset Management
TEVA icon

TD Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History

TD Asset Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.4M Buy
367,355
+113,694
+45% +$3.79M 0.01% 607
2026
Q1 		$7.64M Sell
253,661
-115,362
-31% -$3.71M 0.01% 711
2025
Q4 		$11.5M Buy
369,023
+118,075
+47% +$2.91M 0.01% 622
2025
Q3 		$5.07M Buy
250,948
+10,590
+4% +$186K ﹤0.01% 788
2025
Q2 		$4.03M Buy
240,358
+4,637
+2% +$74.8K ﹤0.01% 796
2025
Q1 		$3.62M Sell
235,721
-198,833
-46% -$3.55M ﹤0.01% 830
2024
Q4 		$9.58M Buy
434,554
+210,860
+94% +$3.84M 0.01% 654
2024
Q3 		$3.91M Sell
223,694
-1,415
-0.6% -$24.8K ﹤0.01% 851
2024
Q2 		$3.66M Buy
225,109
+2,621
+1% +$40.4K ﹤0.01% 835
2024
Q1 		$3.14M Sell
222,488
-5,000
-2% -$63K ﹤0.01% 891
2023
Q4 		$2.37M Buy
227,488
+3,053
+1% +$28.5K ﹤0.01% 954
2023
Q3 		$2.29M Sell
224,435
-1,200
-0.5% -$11.2K ﹤0.01% 923
2023
Q2 		$1.7M Sell
225,635
-1,145
-0.5% -$9.28K ﹤0.01% 1004
2023
Q1 		$2.01M Sell
226,780
-3,486
-2% -$34.5K ﹤0.01% 985
2022
Q4 		$2.1M Sell
230,266
-4,400
-2% -$38.4K ﹤0.01% 974
2022
Q3 		$1.83M Sell
234,666
-7,591
-3% -$67.1K ﹤0.01% 1027
2022
Q2 		$1.82M Sell
242,257
-6,300
-3% -$54.9K ﹤0.01% 1035
2022
Q1 		$2.33M Buy
248,557
+6,500
+3% +$54.2K ﹤0.01% 1041
2021
Q4 		$1.94M Sell
242,057
-6,900
-3% -$62.3K ﹤0.01% 1141
2021
Q3 		$2.42M Sell
248,957
-3,400
-1% -$31.8K ﹤0.01% 1034
2021
Q2 		$2.44M Buy
252,357
+4,200
+2% +$44.5K ﹤0.01% 1033
2021
Q1 		$2.86M Buy
248,157
+2,100
+0.9% +$24.1K ﹤0.01% 997
2020
Q4 		$2.37M Buy
246,057
+1,720
+0.7% +$16.5K ﹤0.01% 989
2020
Q3 		$2.2M Buy
244,337
+7,057
+3% +$74.7K ﹤0.01% 882
2020
Q2 		$2.93M Sell
237,280
-4,200
-2% -$47.5K ﹤0.01% 788
2020
Q1 		$2.17M Sell
241,480
-3,000
-1% -$30.7K ﹤0.01% 818
2019
Q4 		$2.4M Sell
244,480
-65,900
-21% -$588K ﹤0.01% 888
2019
Q3 		$2.13M Sell
310,380
-5,600
-2% -$42.9K ﹤0.01% 898
2019
Q2 		$2.92M Buy
315,980
+24,100
+8% +$291K ﹤0.01% 826
2019
Q1 		$4.58M Buy
291,880
+11,300
+4% +$199K 0.01% 716
2018
Q4 		$4.33M Buy
280,580
+4,600
+2% +$94.3K 0.01% 705
2018
Q3 		$5.95M Buy
275,980
+5,700
+2% +$132K 0.01% 672
2018
Q2 		$6.57M Buy
270,280
+25,200
+10% +$514K 0.01% 628
2018
Q1 		$4.19M Buy
245,080
+1,400
+0.6% +$27.3K 0.01% 719
2017
Q4 		$4.62M Sell
243,680
-74,600
-23% -$1.12M 0.01% 687
2017
Q3 		$5.6M Sell
318,280
-1,882,304
-86% -$42.4M 0.01% 637
2017
Q2 		$73.1M Buy
2,200,584
+96,857
+5% +$3M 0.12% 144
2017
Q1 		$67.5M Sell
2,103,727
-64,519
-3% -$2.2M 0.11% 155
2016
Q4 		$78.6M Buy
2,168,246
+241,049
+13% +$9.62M 0.13% 131
2016
Q3 		$88.7M Buy
1,927,197
+26,132
+1% +$1.36M 0.15% 125
2016
Q2 		$95.5M Buy
1,901,065
+333,797
+21% +$17.8M 0.17% 115
2016
Q1 		$83.9M Sell
1,567,268
-221,416
-12% -$13M 0.16% 115
2015
Q4 		$117M Buy
1,788,684
+615,081
+52% +$38M 0.23% 88
2015
Q3 		$66.3M Buy
1,173,603
+950,651
+426% +$61.6M 0.13% 135
2015
Q2 		$13.2M Sell
222,952
-208,124
-48% -$12.8M 0.02% 443
2015
Q1 		$26.9M Buy
431,076
+171,990
+66% +$10M 0.05% 279
2014
Q4 		$14.9M Buy
259,086
+8,474
+3% +$472K 0.02% 398
2014
Q3 		$13.5M Sell
250,612
-4,745
-2% -$251K 0.02% 407
2014
Q2 		$13.4M Buy
255,357
+93,257
+58% +$4.77M 0.02% 412
2014
Q1 		$8.57M Sell
162,100
-47,825
-23% -$2.21M 0.02% 498
2013
Q4 		$8.41M Sell
209,925
-223,443
-52% -$8.8M 0.02% 492
2013
Q3 		$16.4M Buy
433,368
+53,258
+14% +$2.08M 0.03% 330
2013
Q2 		$14.9M Buy
+380,110
New +$14.8M 0.03% 328

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

TD Asset Management's TEVA Position: Q2 2026 in Review

TD Asset Management increased its Teva Pharmaceuticals (TEVA) stake by 45% in Q2 2026, buying an estimated $3.79M and bringing the position to 367,355 shares worth $12.4M. The position accounts for 0.01% of the portfolio, ranked #607.

TD Asset Management first reported a position in TEVA in Q2 2013 and has held it in 53 quarters since. The position peaked at $117M in Q4 2015. 530 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • TD Asset Management held 367,355 shares of Teva Pharmaceuticals worth $12.4M as of Q2 2026.
  • TD Asset Management bought 113,694 Teva Pharmaceuticals shares in Q2 2026, an estimated $3.79M.
  • Teva Pharmaceuticals made up 0.01% of TD Asset Management's portfolio in Q2 2026, its #607 holding.
  • TD Asset Management first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
  • TD Asset Management's Teva Pharmaceuticals position peaked at $117M in Q4 2015.
  • 530 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on TD Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.